Wellgistics Health Stock (NASDAQ:WGRX)


RevenueOwnershipFinancialsChart

Previous Close

$3.72

52W Range

$3.04 - $97.50

50D Avg

$5.28

200D Avg

$22.71

Market Cap

$8.75M

Avg Vol (3M)

$742.83K

Beta

-1.43

Div Yield

-

WGRX Company Profile


Wellgistics Health, Inc. functions as a primary wholesaler and distributor of pharmaceutical products throughout the United States, catering to both drug manufacturers and independent retail pharmacies. Its extensive product catalog includes a variety of generic and brand-name pharmaceuticals, alongside over-the-counter healthcare and consumer merchandise. The company also delivers a suite of third-party logistics (3PL) services, encompassing warehousing, inventory control, pick-and-pack operations, and shipping solutions, specifically designed for small to mid-sized pharmaceutical producers. Furthermore, Wellgistics manages the DelivMeds platform, an integrated pharmaceutical hub that streamlines prescription transfers and offers essential backend clinical concierge support to its network of independent pharmacies. It also runs a specialized retail community service. Established in 2022 and headquartered in Tampa, Florida, the organization adopted its current name, Wellgistics Health, Inc., in October 2024, having previously operated as Danam Health, Inc.

Show More

Industry

Medical - Distribution

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

31

IPO Date

Feb 25, 2025

Website

WGRX Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24
Product$21.87M$17.67M

Fiscal year ends in Dec 25 | Currency in USD

WGRX Financial Summary


Dec 25Dec 24Dec 23
Revenue$23.34M$18.13M-
Operating Income$-93.75M$-6.15M$-2.88M
Net Income$-101.27M$-6.86M$-2.90M
EBITDA$-90.54M$-4.91M$-2.88M
Basic EPS$-1.43$-0.13$-0.06
Diluted EPS$-1.43$-0.13$-0.06

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison


TickerCompany
KZRKezar Life Sciences, Inc.
MRSNMersana Therapeutics, Inc.
INMBINmune Bio, Inc.
OKUROnKure Therapeutics, Inc.
BDSXBiodesix, Inc.
TELATELA Bio, Inc.
XLOXilio Therapeutics, Inc.
BEATHeartBeam, Inc.
ALGSAligos Therapeutics, Inc.